经导管动脉栓塞术治疗前列腺源性难治性血尿的安全性和有效性
Safety and efficacy of transcatheter arterial embolization for management of refractory hematuria of prostatic origin.
作者信息
Zhang Jinlong, Wang Quanyu, Zhao Hongwei, Yuan Bing, Sun Xuedong, Guan Yang, Fang Zhuting, Wang Maoqiang
机构信息
Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Interventional Department, Huabei Petroleum General Hospital, Renqiu, 062552, China.
出版信息
J Interv Med. 2022 May 21;5(2):84-88. doi: 10.1016/j.jimed.2022.03.005. eCollection 2022 May.
OBJECTIVE
To estimate the safety and efficacy of transcatheter arterial embolization (TAE) in the treatment of refractory hematuria of prostatic origin (RHPO).
METHODS
This retrospective study included 23 patients who underwent TAE for RHPO between May 2013 and August 2021. Technical and clinical success rates were calculated, and arteriogram findings and complications were detected.
RESULTS
Embolization was performed 24 times in 23 patients. Technical success was achieved in 24/24 (100%) embolization procedures. Contrast agent extravasation was detected during 2 of the 24 angiographic procedures. Bilateral embolization was performed in 23 (95.8%) of the 24 procedures. The clinical success rate was 21/23 (91.3%), and hematuria stopped 1-4 days after TAE. No serious complications were observed.
CONCLUSION
TAE is a safe and effective minimally invasive technique for treating patients with RHPO.
目的
评估经导管动脉栓塞术（TAE）治疗前列腺源性难治性血尿（RHPO）的安全性和有效性。
方法
这项回顾性研究纳入了2013年5月至2021年8月期间接受TAE治疗RHPO的23例患者。计算技术成功率和临床成功率，并检测血管造影结果和并发症。
结果
23例患者共进行了24次栓塞。24次栓塞手术均取得技术成功（24/24，100%）。24次血管造影术中，2次检测到造影剂外渗。24次手术中有23次（95.8%）进行了双侧栓塞。临床成功率为21/23（91.3%），TAE术后1 - 4天血尿停止。未观察到严重并发症。
结论
TAE是治疗RHPO患者的一种安全有效的微创技术。
Zotero 插件